Molecular Pathology of Cancer Group

Group leaders

José Palacios Calvo

Belén Pérez Mies

jose.palacios(ELIMINAR)@salud.madrid.org

91 336 83 37

Principal Investigator

  • Alfonso Cortés Salgado

Collaborating Staff

  • Mónica García-Cosío Piqueras
  • Almudena Santón Roldán
  • María Eugenia Reguero Callejas
  • Tamara Caniego Casas
  • Luis Cristian Perna Monroy
  • Marta Gabriela Rosas Hernández
  • Ignacio Ruz Caracuel
  • Irene Carretero del Barrio
  • Silvia González Martínez
  • Elena López Miranda
  • Eva María Guerra Ália
  • María Fernández Abad
  • Noelia Martínez Jáñez
  • Teresa Alonso Gordoa
Imagen equipo

Group leaders

José Palacios Calvo

Belén Pérez Mies

jose.palacios(ELIMINAR)@salud.madrid.org

91 336 83 37

Principal Investigator

  • Alfonso Cortés Salgado

Collaborating Staff

  • Mónica García-Cosío Piqueras
  • Almudena Santón Roldán
  • María Eugenia Reguero Callejas
  • Tamara Caniego Casas
  • Luis Cristian Perna Monroy
  • Marta Gabriela Rosas Hernández
  • Ignacio Ruz Caracuel
  • Irene Carretero del Barrio
  • Silvia González Martínez
  • Elena López Miranda
  • Eva María Guerra Ália
  • María Fernández Abad
  • Noelia Martínez Jáñez
  • Teresa Alonso Gordoa

Strategic objectives

To investigate molecular alterations related to the most aggressive histological types of breast, endometrial, and ovarian cancer, and to determine their potential role as prognostic and predictive factors. Evaluation of new treatments and therapeutic targets.

Research lines

Clinical and molecular characterization of breast, ovarian and endometrial cancer, and its diagnostic, prognostic and predictive implications.

Location

Ramón y Cajal University Hospital

Pathology Department
Floor -3, Left

Keywords

Breast cancer, endometrial cancer, ovarian cancer, molecular pathology, epithelial-mesenchymal transition, prognostic and predictive factors and biomarkers in cancer